Skip to navigation Skip to content

Growth hormone deficiency - paediatric patients Program in Pharmaceutical Benefits Scheme (PBS) 012-63030010



This document outlines details about PBS-subsidised somatrogon and somatropin under the section 100 Growth Hormone (GH) Program for paediatric patients with severe growth hormone deficiency.

Growth Hormone (GH) Program (paediatric use) quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

PB162 form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Must be treated by a:

  • specialist or consultant physician in paediatric endocrinology, or
  • specialist or consultant physician in general paediatrics in consultation with a nominated specialist or consultant physician in paediatric endocrinology

Yes

Continuing

PB163 form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Not specified

Yes

Continuing as reclassified

PB164 Form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Must be treated by a:

  • medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or
  • medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics

Yes

Change (only for SSSG or BGHD)

PB165 form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Must be treated by a:

  • specialist or consultant physician in paediatric endocrinology, or
  • specialist or consultant physician in general paediatrics in consultation with a nominated specialist or consultant physician in paediatric endocrinology

Yes

Recommencement

PB165 form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Must be treated by a:

  • medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or
  • medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics

Yes

Recommencement as reclassified

PB166 form

Written

Electronic

S100:

  • somatrogon
  • somatropin

Yes

OPA

Must be treated by a:

  • medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or
  • medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics

Yes

Grandfather

PB339 form

Written

Electronic

S100:

somatrogon

Yes

OPA

Must be treated by a:

  • medical practitioner in consultation with a nominated specialist or consultant physician in paediatric endocrinology, or
  • medical practitioner in consultation with a nominated specialist or consultant physician in general paediatrics

Yes